Bhoomendra Bhongade
Ras Al Khaimah Medical and Health Sciences University College of Pharmaceutical Sciences
Research areas: Chemistry · Organic Chemistry · Computational Drug Discovery Methods · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds
0000-0002-4057-7125
About
Dr. Bhoomendra Bhongade is a Professor of Pharmaceutical Chemistry at the College of Pharmaceutical Sciences, Ras Al Khaimah Medical and Health Sciences University (RAKMHSU), UAE. He holds a Ph.D. in Pharmaceutical Chemistry and has extensive academic and research experience across India, Malaysia, and the Caribbean.
His research focuses on molecular modelling, computer-aided drug design (CADD), synthesis of bioactive heterocyclic compounds, and the application of spectroscopic techniques, particularly FTIR, in pharmaceutical analysis. His work aims at the discovery and development of novel therapeutic agents for the management of complex diseases, including metabolic disorders.
Dr. Bhongade is a recipient of the CSIR Senior Research Fellowship (India) and has completed postdoctoral research at the University of the West Indies, Trinidad and Tobago. He has also served as faculty at the International Medical University, Kuala Lumpur. He is actively involved in teaching, mentoring, and collaborative research, contributing to the advancement of pharmaceutical sciences.
Employment
-
Ras Al Khaimah Medical and Health Sciences University College of Pharmaceutical Sciences Professor2010 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (54)
- Diffuse Reflectance Infrared Fourier Transform Spectroscopy in Pharmaceutical Analysis: Applications, Constraints and Regulatory Readiness—A Critical Review Save
- Gold Nanostars: Emerging Plasmonic Nanoplatforms for Lung Cancer Diagnosis and Therapy Save
- An Overview of Cushing’s Syndrome Caused by Ectopic Adrenocorticotropin Secretion Save
- Vitamin D–VDR Signaling Across Thyroid Disorders: A Systematic Review of Molecular Mechanisms, Autoimmunity, Genetic Susceptibility, Experimental Evidence and Therapeutic Translation Save
- Pathological Complete Response to Nab-Paclitaxel–Containing Neoadjuvant Regimens in Early Triple-Negative Breast Cancer: A Systematic Review and Meta-Analysis Save
- Targeting the Gut–Bone Axis with Prebiotics, Probiotics, Synbiotics, and Postbiotics: From Mechanistic Plausibility to Clinical Bone Outcomes Save
- Mesenteric Panniculitis and the Gut–Mesentery–Metabolic Axis: A Hypothesis-Generating Narrative Review Save
- Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer Save
- New Benzimidazole Scaffolds Tagged With Isatin/Thiourea Motifs as Anti‐Cancer Agents: Promising Approach for VEGFR‐2 Inhibition Save
- Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management Save
- Vitamin D supplementation and selected metabolic parameters in patients with type 2 diabetes and obesity: a prospective observational study Save
- Antifibrotic Efficacy of Daclatasvir Against Pulmonary Fibrosis: Insights From Network Pharmacology, Molecular Docking, Dynamics, and Preclinical Evaluations Save
- Therapeutic Potentials of Phytochemicals in Pancreatitis: Targeting Calcium Signaling, Ferroptosis, microRNAs, and Inflammation with Drug-Likeness Evaluation Save
- Natural compounds as PPAR-γ modulators in inflammatory bowel disease: Insights from molecular docking and dynamics simulations Save
- The Effect of Proton Pump Inhibitors on Bone Mineral Density at Specific Anatomical Sites: A Systematic Review and Meta‐Analysis Save
- In vitro and in silico investigation of effects of antimicrobial peptides from Solanaceae plants against rice sheath blight pathogen Rhizoctinia solani Save
- Design, synthesis, and in silico insights into dual-inhibition of CDK-6/Aurora A kinase by 2-phenylbenzimidazole-based small molecules Save
- Exploration of antiproliferative potential of modified triazole–benzohydrazone scaffold: Multitarget approach Save
- Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation Save
- Molecular Docking Identifies 1,8-Cineole (Eucalyptol) as A Novel PPARγ Agonist That Alleviates Colon Inflammation Save